Skip to main content
SpringerLink
Log in

Methylation of the Putative Tumor Suppressor Gene RASSF1A in Primary Cervical Tumors

  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

Methylation-sensitive restriction endonuclease analysis (MSRA) followed by polymerase chain reaction (PCR) have been used to estimate the methylation level of 13 CpG dinucleotides in the promoter region of the putative suppressor gene RASSF1A (3p21.31) in squamous cell carcinomas of the uterine cervix (SCCs) carrying human papillomavirus (HPV) types 16, 18, and related types. Methylation of 3 to 13 CpG pairs has been found in 64% (25 out of 39) tumor DNA samples, 22% (2 out of 9) DNA samples from morphologically normal tissues adjacent to the tumor (P = 0.0306), and two out of three DNA samples from peripheral blood leukocytes of carcinoma patients. These CpG pairs are not methylated in the DNA of leukocytes of healthy donors (0 out of 10). The methylation level of the RASSF1A promoter region studied in tumors of the patients with regional lymph node metastases is significantly higher than in tumors of the patient that have no metastases (P = 8.5 × 10–12). The methylation frequency of gene RASSF1A is two times higher than the frequency of hemi- and homozygous deletions in the chromosome 3 region where the gene is located. The data obtained indicate that methylation is one of the main mechanisms of the RASSF1A gene inactivation in HPV-positive human cervical tumors. The methylation of this gene may be an early event in the genesis of cervical tumors, the methylation level increasing with tumor progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. WHO Press Release. WHO. 1996. 47.

  2. Greenlee R.T., Murray T., Bolden S., Wingo P.A. 2000. Cancer statistics. CA Cancer J. Clin. 50, 7–33.

    Google Scholar 

  3. Smith H.O., Tiffany M.F., Qualls C.R., Key C.R. 2000. The rising incidence of adenocarcinoma relative to squa-mous cell carcinoma of the uterine cervix in the United States: A 24-year population-based study. Gynecol. Oncol. 78, 97–105.

    Google Scholar 

  4. Zur Hausen H. 2002. Papillomaviruses and cancer: From basic studies to clinical application (Review). Nature Rev. Cancer. 2, 342–350.

    Google Scholar 

  5. Herman J.G. 1999. Hypermethylation of tumor suppres-sor genes in cancer. Seminars Cancer Biol. 9, 359–367.

    Google Scholar 

  6. Rader J.S., Kamarasova T., Huettner P.C., Li L., Li Y., Gerhard D.S. 1996. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene. 13, 273-2741.

    Google Scholar 

  7. Kisseljov F., Semjonova L., Samoylova E., Mazurenko N., Komissarova E., Zourbitskaya V., Gritzko T., Koza-chenko V., Netchuskin M., Petrov S., Smirnov A., Alonso A. 1996. Instability of chromosome 6 microsat-ellite repeats in human cervical tumors carrying papillo-mavirus sequences. Int. J. Cancer. 69, 484–487.

    Google Scholar 

  8. Wistuba I.I., Montellano F.D., Milchgrub S., Virmani A.K., Behrens C., Chen H., Ahmadian M., Nowak J.A., Muller C., Minna J.D., Gazdar A.F. 1997. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res. 57, 315-3158.

    Google Scholar 

  9. Kersemaekers A.M., Hermans J., Fleuren G.J., van de Vijver M.J. 1998. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carci-nomas of the uterine cervix. Brit. J. Cancer. 77, 19-200.

    Google Scholar 

  10. Mazurenko N., Attaleb M., Gritzko T., Semjonova L., Pavlova L., Sakharova O., Kisseljov F. 1999. High reso-lution mapping of chromosome 6 deletions in cervical cancer. Oncol. Reports. 6, 859–863.

    Google Scholar 

  11. Acevedo C.M., Henriquez M., Emmert-Buck M.R., Chuaqui R.F. 2002. Loss of heterozygosity on chromo-some arms 3p and 6q in microdissected adenocarcino-mas of the uterine cervix and adenocarcinoma in situ. Cancer. 94, 793–802.

    Google Scholar 

  12. Mazurenko N., Belyakov I., Bliev A., Guo Zh., Hu K., Vinokurova S., Bidzhieva B., Pavlova L., Ponten Ya., Kisseljov F. 2003. Genetic changes associated with cer-vical cancer progression on chromosome 6. Mol. Biol. 37, 472–481.

    Google Scholar 

  13. Dreijerink K., Braga E., Kuzmin I., Geil L., Duh F.M., Angeloni D., Zbar B., Lerman M.I., Stanbridge E.J., Minna J.D., Protopopov A., Li J., Kashuba V., Klein G., Zabarovsky E.R. 2001. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl. Acad. Sci. USA. 98, 7504–7509.

    Google Scholar 

  14. Pfeifer G.P., Yoon J.-H., Liu L., Tommasi S., Wilczynski Sh.P., Dammann R. 2002. Methylation of the RASSF1A gene in human cancers. Biol. Chem. 383, 907–914.

    Google Scholar 

  15. Loginov W.I., Malyukova A.V., Kazubskaya T.P., Hodyrev D.S., Seryogin Yu.A., Ermilova V.D., Garkav-tseva R.F., Kisselev L.L., Zabarovsky E.R., Braga E.A. 2004. Methylation level of the RASSF1A promoter region in primary epithelial tumors. Mol. Biol. 38, 65-667.

    Google Scholar 

  16. Tomizawa Y., Kohno T., Kondo H., Otsuka A., Nishioka M., Niki T., Yamada T., Maeshima A., Yoshimura K., Saito R., Minna J.D., Yokota J. 2002. Clinicopathological signifi-cance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin. Cancer Res. 8, 2362–2368.

    Google Scholar 

  17. Muller H.M., Widschwendter A., Fiegl H., Ivarsson L., Goebel G., Perkmann E., Marth C., Widschwendter M. 2003. DNA methylation in serum of breast cancer patients: An independent prognostic marker. Cancer Res. 63, 7641–7645.

    Google Scholar 

  18. Kuzmin I., Liu L., Dammann R., Geil L., Stanbridge E.J., Wilczynski S.P., Lerman M.I., Pfeifer G.P. 2003. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papilloma-virus infection. Cancer Res. 63, 1888–1893.

    Google Scholar 

  19. Cohen Y., Singer G., Lavie O., Dong S.M., Beller U., Sidransky D. 2003. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Clin. Cancer Res. 9, 2981–2984.

    Google Scholar 

  20. Yu M.Y., Tong J.H., Chan P.K., Lee T.L., Chan M.W., Chan A.W., Lo K.W., To K.F. 2003. Hypermethylation of the tumor suppressor gene RASSFIA and frequent con-comitant loss of heterozygosity at 3p21 in cervical cancers. Int. J. Cancer. 105, 204–209.

    Google Scholar 

  21. Samoylova E., Shaikhaev G., Petrov S., Kisseljova N., Kisseljov F. 1995. HPV infection in cervical cancer cases in Russia. Int. J. Cancer. 61, 337–341.

    Google Scholar 

  22. Ivanova T., Petrenko A., Gritsko T., Vinokourova S., Eshilev E., Kobzeva V., Kisseljov F., Kisseljova N. 2002. Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer. BMC Cancer. 2, 4 (el).

    Google Scholar 

  23. Braga E., Senchenko V., Bazov I., Loginov W., Ermilova V., Kazubskaya T., Garkavtseva R., Mazurenko N., Kissel jov F., Liu J., Lerman M.I., Kisselev L., Klein G., Zabarovsky E. 2002. Critical tumor-suppressor gene regions on chromosome 3p in major human epithelial malignancies: Allelotyping and quantitative real-time PCR. Int. J. Cancer. 100, 534–541.

    Google Scholar 

  24. Braga E.A., Loginov W.I., Malyukova A.V., Kilosanidze G., Senchenko V.N., Seryogin Yu.A., Barkevich O.A., Kashuba V.I., Ermilova V.D., Kazubskaya T.P., Garkav-tseva R.F., Kisselev L.L., Zabarovsky E.R. 2003. Proc. 7th Russian Oncological Congress, Moscow, 141–144.

  25. Braga E.A., Kisselev L.L., Zabarovsky E.R. 2004. From identification of genomic polymorphisms to diagnostic and prognostic markers of human epithelial tumors. Mol. Biol. 38, 179–190.

    Google Scholar 

  26. Senchenko V., Liu J., Braga E., Mazurenko N., Loginov W., Seryogin Y., Bazov I., Kisseljov F., Kashuba V., Lerman M.I., Klein G., Zabarovsky E. 2003. Deletion mapping of cervical carcinomas using quantitative real-time PCR identifies two frequently affected regions in 3p21.3. Oncogene. 22, 2984–2992.

    Google Scholar 

  27. Toyooka S., Toyooka K.O., Maruyama R., Virmani A.K., Girard L., Miyajima K., Harada K., Arioshy Y., Takahashi T., Sugio K., Brambilla E., Gilcrease M., Minna J.D., Gazdar A.F. 2001. DNA methylation profiles of lung tumors. Mol. Cancer Ther. 1, 61–67.

    Google Scholar 

  28. Vos M.D., Ellis C.A., Bell A., Birrer M.J., Clark G.J. 2000. Ras uses the novel tumor suppressor RASSF1A as an effector to mediate apoptosis. J. Biol. Chem. 275, 35669–35672.

    Google Scholar 

  29. Shivakumar L., Minna J., Sakamaki T., Pestell R., White M.A. 2002. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell Biol. 22, 4309–4318.

    Google Scholar 

  30. Braga E.A., Kashuba V.I., Malyukova A.V., Loginov W.I., Senchenko V.N., Bazov I.V., Kisselev L.L., Zaba-rovsky E.R. 2003. Novel tumor suppressor genes in hot spots of human chromosome 3: New methods of identification. Mol. Biol. 37, 194–211.

    Google Scholar 

  31. Dammann R., Schagdarsurengin U., Strunnikova M., Rastetter M., Seidel C., Liu L., Tommasi S., Pfeifer G.P. 2003. Epigenetic inactivation of Ras-association domain family 1 (RASSF1A) gene and its function in human car-cinogenesis. Histol. Histopathol. 18, 665–677.

    Google Scholar 

  32. Waki T., Tamara G., Makoto S., Motoyama T. 2003. Age-related methylation of tumor suppressor and tumor-related genes: An analysis of autopsy samples. Oncogene. 22, 4128–4133.

    Google Scholar 

  33. Cui H., Horon I., Oholsson R., Hamilton S., Feinberg A. 1998. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nature Med. 4, 1276–1280.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. State Research Center GosNIIgenetika, Moscow, 117545, Russia

    A. V. Malyukova, W. I. Loginov, D. S. Hodyrev, E. L. Kadyrova, I. V. Pronina & E. A. Braga

  2. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, 115478, Russia

    E. L. Kadyrova, T. A. Ivanova, F. L. Kisseljov & N. P. Kisseljova

  3. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia

    E. R. Zabarovsky

  4. Microbiology and Tumor Biology Center and Center for Genomics and Bioinformatics, Karolinska Institute, Stockholm, 17177, Sweden

    E. R. Zabarovsky

Authors
  1. A. V. Malyukova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. I. Loginov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. S. Hodyrev
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. L. Kadyrova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. V. Pronina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. A. Ivanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. L. Kisseljov
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. R. Zabarovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. N. P. Kisseljova
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E. A. Braga
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malyukova, A.V., Loginov, W.I., Hodyrev, D.S. et al. Methylation of the Putative Tumor Suppressor Gene RASSF1A in Primary Cervical Tumors. Molecular Biology 38, 857–864 (2004). https://doi.org/10.1023/B:MBIL.0000049862.84087.bf

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MBIL.0000049862.84087.bf

Search

Navigation